ResearchWeight Gain Was Associated With Worsening Glycemia and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes Independent of Diabetes Medication in the GRADE Randomized Controlled Trial
ResearchLongitudinal Metabolic Trajectories in Diabetes Prevention Program Participants Reveal Subgroups With Varying Micro- and Macrovascular Complication Risks
ResearchImpact of Parental or First-Degree Family History of Diabetes on Diabetes Incidence and Progression During Long-term Follow-up in the Diabetes Prevention Program Outcomes Study
ResearchDifferences in Prevalence and Incidence of Electrocardiogram Abnormalities and Cardiovascular Autonomic Neuropathy Among Randomized Glucose-Lowering Treatments in Early Type 2 Diabetes: The Glycemia Reduction Approaches in Diabetes (GRADE) Cohort
ResearchType 2 Diabetes Moderates the Association Between Amyloid and 1-Year Change in Everyday Functioning in Older Veterans
Feb 12, 2024Journal ArticleCardiovascular Outcomes in GRADE (Glycemia Reduction Approaches in Type 2 Diabetes: A Comparative Effectiveness Study).Written by 1 Roon author & 14 others Via The American Heart Association Journals
ResearchThe Evolution of Diabetes Treatment Through the Ages: From Starvation Diets to Insulin, Incretins, SGLT2-Inhibitors and Beyond
ResearchAstaxanthin, a Natural Antioxidant, Lowers Cholesterol and Markers of Cardiovascular Risk in Individuals with Prediabetes and Dyslipidaemia
ResearchComparative Effects of Glucose-Lowering Medications on Kidney Outcomes in Type 2 Diabetes: The GRADE Randomized Clinical Trial
ResearchPotential Underlying Mechanisms Explaining the Cardiorenal Benefits of Sodium-Glucose Cotransporter 2 Inhibitors
ResearchSodium-Glucose Co-Transporter-2 Inhibitors in Patients with Type 2 Diabetes: Barriers and Solutions for Improving Uptake in Routine Clinical Practice
ResearchIncrease in Hematocrit with SGLT-2 Inhibitors — Hemoconcentration from Diuresis or Increased Erythropoiesis after Amelioration of Hypoxia?
ResearchSGLT2 Inhibitor-Induced Low-Grade Ketonemia Ameliorates Retinal Hypoxia in Diabetic Retinopathy — A Novel Hypothesis
ResearchA Novel Hypothesis Linking Low-Grade Ketonaemia to Cardio-Renal Benefits with Sodium-Glucose Cotransporter-2 Inhibitors